Peripheral Vascular Disease

Transmembrane stem cell factor protein therapeutics enhance revascularization in ischemia without mast cell activation
Stem cell factor (SCF) is a cytokine that regulates hematopoiesis and other biological processes. While clinical treatments using SCF …
PDF DOI Cite bioRxiv
Mechanobiological conditioning of mesenchymal stem cells for enhanced vascular regeneration
Using endogenous mesenchymal stem cells for treating myocardial infarction and other cardiovascular conditions typically results in …
PDF DOI Cite bioRxiv
Glioblastoma exosomes for therapeutic angiogenesis in peripheral ischemia
Peripheral ischemia as a result of occlusive vascular disease is a widespread problem in patients older than the age of 65. Angiogenic …
PDF DOI Cite
Glypican-1 nanoliposomes for potentiating growth factor activity in therapeutic angiogenesis
Therapeutic angiogenesis is a highly appealing concept for treating tissues that become ischemic due to vascular disease. A major …
PDF DOI Cite
Syndecan-4 Enhances Therapeutic Angiogenesis after Hind Limb Ischemia in Mice with Type 2 Diabetes
Delivering syndecan-4 with FGF-2 improves the effectiveness of FGF-2 therapy for ischemia in the diabetic disease state. The syndecan-4 …
PDF DOI Cite